Welcome to LookChem.com Sign In|Join Free
  • or
C19H22N2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

23130-89-4

Post Buying Request

23130-89-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23130-89-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 23130-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,1,3 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 23130-89:
(7*2)+(6*3)+(5*1)+(4*3)+(3*0)+(2*8)+(1*9)=74
74 % 10 = 4
So 23130-89-4 is a valid CAS Registry Number.

23130-89-4Relevant academic research and scientific papers

A mild procedure for the Lewis acid-catalyzed ring-opening of activated cyclopropanes with amine nucleophiles

Lifchits, Olga,Charette, Andre B.

supporting information; experimental part, p. 2809 - 2812 (2009/05/27)

(Chemical Equation Presented) The Lewis acid-catalyzed ring-opening of methyl 1-nitrocyclopropanecarboxylates with amine nucleophiles is described. The reaction proceeds at room temperature and with complete preservation of the enantiomeric purity from th

Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines

Mahaney, Paige E.,Vu, An T.,McComas, Casey C.,Zhang, Puwen,Nogle, Lisa M.,Watts, William L.,Sarkahian, Ani,Leventhal, Liza,Sullivan, Nicole R.,Uveges, Albert J.,Trybulski, Eugene J.

, p. 8455 - 8466 (2008/02/04)

Compounds with a combination of norepinephrine and serotonin reuptake inhibition have been approved in the US and Europe for a number of indications, including major depressive disorder and pain disorders such as diabetic neuropathy and fibromyalgia. Efforts to design selective norepinephrine reuptake inhibitors based on SAR from the aryloxypropanamine series of monoamine reuptake inhibitors have led to the identification of a potent new class of dual acting norepinephrine and serotonin reuptake inhibitors, namely the 3-(1H-indol-1-yl)-3-arylpropan-1-amines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23130-89-4